Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems,
Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems, according to Steve Sickels, divisionmanager.
Toshiba displayed transmission-emission attenuation correctionas a work-in-progress at last year's Radiological Society of NorthAmerica meeting. The technique was shown on Toshiba's triple-headGCA-9300A camera, but Toshiba also has an active R&D programin Japan to bring the technology to the dual-head GCA-7200A, accordingto Sickels. The dual-head version, which is also a work-in-progress,will involve a combination of a stationary line source of radioactivityand collimation, he said. GCA-7200A is an opposable dual-headcamera.
Toshiba also has a program in the works to develop 511-keVcollimators for SPECT imaging with fluorodeoxyglucose (FDG), Sickelssaid.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Suggests CT-Guided Injections May Restore Sense of Smell in Patients with Long COVID
November 20th 2023Utilizing computed tomography (CT) guidance, researchers have found that performing a minimally invasive anesthetic injection into the stellate ganglia may help address parosmia due to COVID-19, according to study results that will be presented at the annual Radiological Society of North America (RSNA) conference next week.